A Pilot Study Investigating Apixaban and Dexamethasone InterAction in Multiple Myeloma
NCT02749617
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
2
Enrollment
OTHER
Sponsor class
Stopped
Study was stopped due to lack of enrollment.
Conditions
Anti-Xa Activity
Interventions
DRUG:
apixaban
Sponsor
University of British Columbia